nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadopentetate dimeglumine—PGD—Dacarbazine—pancreatic cancer	0.821	1	CbGbCtD
Gadopentetate dimeglumine—Nasopharyngitis—Epirubicin—pancreatic cancer	0.000155	0.000869	CcSEcCtD
Gadopentetate dimeglumine—Face oedema—Doxorubicin—pancreatic cancer	0.000155	0.000868	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Docetaxel—pancreatic cancer	0.000155	0.000867	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Gemcitabine—pancreatic cancer	0.000155	0.000867	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Tamoxifen—pancreatic cancer	0.000154	0.000862	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000154	0.000861	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Gemcitabine—pancreatic cancer	0.000154	0.00086	CcSEcCtD
Gadopentetate dimeglumine—Cardiac arrest—Doxorubicin—pancreatic cancer	0.000153	0.000855	CcSEcCtD
Gadopentetate dimeglumine—Pain—Gemcitabine—pancreatic cancer	0.000153	0.000853	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Gemcitabine—pancreatic cancer	0.000153	0.000853	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Erlotinib—pancreatic cancer	0.000153	0.000853	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Fluorouracil—pancreatic cancer	0.000153	0.000853	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Sunitinib—pancreatic cancer	0.000152	0.000851	CcSEcCtD
Gadopentetate dimeglumine—Dysgeusia—Docetaxel—pancreatic cancer	0.000152	0.000849	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000151	0.000847	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Irinotecan—pancreatic cancer	0.000151	0.000844	CcSEcCtD
Gadopentetate dimeglumine—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.000151	0.000842	CcSEcCtD
Gadopentetate dimeglumine—Back pain—Docetaxel—pancreatic cancer	0.00015	0.000839	CcSEcCtD
Gadopentetate dimeglumine—Pain—Fluorouracil—pancreatic cancer	0.00015	0.000839	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.00015	0.000837	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Sunitinib—pancreatic cancer	0.000147	0.000822	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000147	0.000822	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.000147	0.000821	CcSEcCtD
Gadopentetate dimeglumine—Angina pectoris—Epirubicin—pancreatic cancer	0.000146	0.000818	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Irinotecan—pancreatic cancer	0.000145	0.00081	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Irinotecan—pancreatic cancer	0.000145	0.00081	CcSEcCtD
Gadopentetate dimeglumine—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.000145	0.000809	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000145	0.000808	CcSEcCtD
Gadopentetate dimeglumine—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.000144	0.000804	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Sunitinib—pancreatic cancer	0.000141	0.00079	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Gemcitabine—pancreatic cancer	0.000141	0.000789	CcSEcCtD
Gadopentetate dimeglumine—Rash—Sunitinib—pancreatic cancer	0.00014	0.000784	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Sunitinib—pancreatic cancer	0.00014	0.000783	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Fluorouracil—pancreatic cancer	0.000139	0.000779	CcSEcCtD
Gadopentetate dimeglumine—Headache—Sunitinib—pancreatic cancer	0.000139	0.000779	CcSEcCtD
Gadopentetate dimeglumine—Syncope—Docetaxel—pancreatic cancer	0.000139	0.000778	CcSEcCtD
Gadopentetate dimeglumine—Pollakiuria—Epirubicin—pancreatic cancer	0.000139	0.000776	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Fluorouracil—pancreatic cancer	0.000139	0.000775	CcSEcCtD
Gadopentetate dimeglumine—Loss of consciousness—Docetaxel—pancreatic cancer	0.000136	0.000762	CcSEcCtD
Gadopentetate dimeglumine—Cough—Docetaxel—pancreatic cancer	0.000135	0.000757	CcSEcCtD
Gadopentetate dimeglumine—Angina pectoris—Doxorubicin—pancreatic cancer	0.000135	0.000757	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Irinotecan—pancreatic cancer	0.000135	0.000754	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Docetaxel—pancreatic cancer	0.000134	0.000752	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Docetaxel—pancreatic cancer	0.000134	0.000749	CcSEcCtD
Gadopentetate dimeglumine—Drowsiness—Epirubicin—pancreatic cancer	0.000134	0.000749	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Docetaxel—pancreatic cancer	0.000132	0.000738	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Docetaxel—pancreatic cancer	0.000132	0.000738	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Sunitinib—pancreatic cancer	0.000132	0.000738	CcSEcCtD
Gadopentetate dimeglumine—Renal failure—Epirubicin—pancreatic cancer	0.000132	0.000736	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Irinotecan—pancreatic cancer	0.000131	0.000735	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000131	0.000733	CcSEcCtD
Gadopentetate dimeglumine—Conjunctivitis—Epirubicin—pancreatic cancer	0.00013	0.000728	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000129	0.000723	CcSEcCtD
Gadopentetate dimeglumine—Dry mouth—Docetaxel—pancreatic cancer	0.000129	0.000722	CcSEcCtD
Gadopentetate dimeglumine—Sweating—Epirubicin—pancreatic cancer	0.000128	0.000718	CcSEcCtD
Gadopentetate dimeglumine—Pollakiuria—Doxorubicin—pancreatic cancer	0.000128	0.000718	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Gemcitabine—pancreatic cancer	0.000128	0.000716	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Docetaxel—pancreatic cancer	0.000128	0.000714	CcSEcCtD
Gadopentetate dimeglumine—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000127	0.000708	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000127	0.000708	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Gemcitabine—pancreatic cancer	0.000126	0.000706	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Irinotecan—pancreatic cancer	0.000125	0.000701	CcSEcCtD
Gadopentetate dimeglumine—Shock—Docetaxel—pancreatic cancer	0.000125	0.000696	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Docetaxel—pancreatic cancer	0.000124	0.000694	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Fluorouracil—pancreatic cancer	0.000124	0.000694	CcSEcCtD
Gadopentetate dimeglumine—Drowsiness—Doxorubicin—pancreatic cancer	0.000124	0.000693	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Docetaxel—pancreatic cancer	0.000124	0.000691	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Docetaxel—pancreatic cancer	0.000123	0.000688	CcSEcCtD
Gadopentetate dimeglumine—Bradycardia—Epirubicin—pancreatic cancer	0.000122	0.000684	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Gemcitabine—pancreatic cancer	0.000122	0.000683	CcSEcCtD
Gadopentetate dimeglumine—Renal failure—Doxorubicin—pancreatic cancer	0.000122	0.000681	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Irinotecan—pancreatic cancer	0.000121	0.000677	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Docetaxel—pancreatic cancer	0.000121	0.000675	CcSEcCtD
Gadopentetate dimeglumine—Rhinitis—Epirubicin—pancreatic cancer	0.000121	0.000674	CcSEcCtD
Gadopentetate dimeglumine—Conjunctivitis—Doxorubicin—pancreatic cancer	0.00012	0.000673	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Fluorouracil—pancreatic cancer	0.00012	0.000671	CcSEcCtD
Gadopentetate dimeglumine—Sweating—Doxorubicin—pancreatic cancer	0.000119	0.000664	CcSEcCtD
Gadopentetate dimeglumine—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000119	0.000664	CcSEcCtD
Gadopentetate dimeglumine—Oedema peripheral—Epirubicin—pancreatic cancer	0.000118	0.000662	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Docetaxel—pancreatic cancer	0.000118	0.000661	CcSEcCtD
Gadopentetate dimeglumine—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000118	0.00066	CcSEcCtD
Gadopentetate dimeglumine—Urethral disorder—Epirubicin—pancreatic cancer	0.000118	0.000659	CcSEcCtD
Gadopentetate dimeglumine—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000117	0.000655	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Irinotecan—pancreatic cancer	0.000116	0.000651	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Fluorouracil—pancreatic cancer	0.000116	0.000649	CcSEcCtD
Gadopentetate dimeglumine—Visual impairment—Epirubicin—pancreatic cancer	0.000116	0.000648	CcSEcCtD
Gadopentetate dimeglumine—Rash—Irinotecan—pancreatic cancer	0.000116	0.000646	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Irinotecan—pancreatic cancer	0.000115	0.000645	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000115	0.000645	CcSEcCtD
Gadopentetate dimeglumine—Headache—Irinotecan—pancreatic cancer	0.000115	0.000642	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Docetaxel—pancreatic cancer	0.000114	0.000636	CcSEcCtD
Gadopentetate dimeglumine—Erythema multiforme—Epirubicin—pancreatic cancer	0.000114	0.000635	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Gemcitabine—pancreatic cancer	0.000113	0.000634	CcSEcCtD
Gadopentetate dimeglumine—Bradycardia—Doxorubicin—pancreatic cancer	0.000113	0.000633	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Docetaxel—pancreatic cancer	0.000113	0.000631	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Docetaxel—pancreatic cancer	0.000113	0.000629	CcSEcCtD
Gadopentetate dimeglumine—Rash—Gemcitabine—pancreatic cancer	0.000113	0.000629	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Gemcitabine—pancreatic cancer	0.000112	0.000628	CcSEcCtD
Gadopentetate dimeglumine—Eye disorder—Epirubicin—pancreatic cancer	0.000112	0.000628	CcSEcCtD
Gadopentetate dimeglumine—Tinnitus—Epirubicin—pancreatic cancer	0.000112	0.000627	CcSEcCtD
Gadopentetate dimeglumine—Headache—Gemcitabine—pancreatic cancer	0.000112	0.000625	CcSEcCtD
Gadopentetate dimeglumine—Flushing—Epirubicin—pancreatic cancer	0.000112	0.000624	CcSEcCtD
Gadopentetate dimeglumine—Cardiac disorder—Epirubicin—pancreatic cancer	0.000112	0.000624	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Fluorouracil—pancreatic cancer	0.000112	0.000624	CcSEcCtD
Gadopentetate dimeglumine—Rhinitis—Doxorubicin—pancreatic cancer	0.000112	0.000623	CcSEcCtD
Gadopentetate dimeglumine—Rash—Fluorouracil—pancreatic cancer	0.000111	0.000618	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Fluorouracil—pancreatic cancer	0.000111	0.000618	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Docetaxel—pancreatic cancer	0.00011	0.000615	CcSEcCtD
Gadopentetate dimeglumine—Headache—Fluorouracil—pancreatic cancer	0.00011	0.000614	CcSEcCtD
Gadopentetate dimeglumine—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.00011	0.000614	CcSEcCtD
Gadopentetate dimeglumine—Oedema peripheral—Doxorubicin—pancreatic cancer	0.00011	0.000613	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000109	0.000611	CcSEcCtD
Gadopentetate dimeglumine—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000109	0.000611	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Docetaxel—pancreatic cancer	0.000109	0.00061	CcSEcCtD
Gadopentetate dimeglumine—Angiopathy—Epirubicin—pancreatic cancer	0.000109	0.00061	CcSEcCtD
Gadopentetate dimeglumine—Urethral disorder—Doxorubicin—pancreatic cancer	0.000109	0.00061	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Irinotecan—pancreatic cancer	0.000109	0.000608	CcSEcCtD
Gadopentetate dimeglumine—Immune system disorder—Epirubicin—pancreatic cancer	0.000109	0.000607	CcSEcCtD
Gadopentetate dimeglumine—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000108	0.000606	CcSEcCtD
Gadopentetate dimeglumine—Pain—Docetaxel—pancreatic cancer	0.000108	0.000605	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Docetaxel—pancreatic cancer	0.000108	0.000605	CcSEcCtD
Gadopentetate dimeglumine—Chills—Epirubicin—pancreatic cancer	0.000108	0.000603	CcSEcCtD
Gadopentetate dimeglumine—Arrhythmia—Epirubicin—pancreatic cancer	0.000107	0.0006	CcSEcCtD
Gadopentetate dimeglumine—Visual impairment—Doxorubicin—pancreatic cancer	0.000107	0.000599	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Gemcitabine—pancreatic cancer	0.000106	0.000593	CcSEcCtD
Gadopentetate dimeglumine—Mental disorder—Epirubicin—pancreatic cancer	0.000105	0.000589	CcSEcCtD
Gadopentetate dimeglumine—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000105	0.000588	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Epirubicin—pancreatic cancer	0.000105	0.000585	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Docetaxel—pancreatic cancer	0.000104	0.000583	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Fluorouracil—pancreatic cancer	0.000104	0.000583	CcSEcCtD
Gadopentetate dimeglumine—Eye disorder—Doxorubicin—pancreatic cancer	0.000104	0.000581	CcSEcCtD
Gadopentetate dimeglumine—Tinnitus—Doxorubicin—pancreatic cancer	0.000104	0.00058	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000104	0.000579	CcSEcCtD
Gadopentetate dimeglumine—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000103	0.000577	CcSEcCtD
Gadopentetate dimeglumine—Flushing—Doxorubicin—pancreatic cancer	0.000103	0.000577	CcSEcCtD
Gadopentetate dimeglumine—Tension—Epirubicin—pancreatic cancer	0.000103	0.000574	CcSEcCtD
Gadopentetate dimeglumine—Dysgeusia—Epirubicin—pancreatic cancer	0.000102	0.000573	CcSEcCtD
Gadopentetate dimeglumine—Back pain—Epirubicin—pancreatic cancer	0.000101	0.000566	CcSEcCtD
Gadopentetate dimeglumine—Angiopathy—Doxorubicin—pancreatic cancer	0.000101	0.000564	CcSEcCtD
Gadopentetate dimeglumine—Immune system disorder—Doxorubicin—pancreatic cancer	0.0001	0.000562	CcSEcCtD
Gadopentetate dimeglumine—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.0001	0.00056	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Docetaxel—pancreatic cancer	0.0001	0.00056	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Docetaxel—pancreatic cancer	0.0001	0.00056	CcSEcCtD
Gadopentetate dimeglumine—Chills—Doxorubicin—pancreatic cancer	9.98e-05	0.000558	CcSEcCtD
Gadopentetate dimeglumine—Arrhythmia—Doxorubicin—pancreatic cancer	9.94e-05	0.000556	CcSEcCtD
Gadopentetate dimeglumine—Mental disorder—Doxorubicin—pancreatic cancer	9.75e-05	0.000545	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Doxorubicin—pancreatic cancer	9.68e-05	0.000541	CcSEcCtD
Gadopentetate dimeglumine—Agitation—Epirubicin—pancreatic cancer	9.62e-05	0.000538	CcSEcCtD
Gadopentetate dimeglumine—Tension—Doxorubicin—pancreatic cancer	9.5e-05	0.000531	CcSEcCtD
Gadopentetate dimeglumine—Dysgeusia—Doxorubicin—pancreatic cancer	9.48e-05	0.00053	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Epirubicin—pancreatic cancer	9.44e-05	0.000528	CcSEcCtD
Gadopentetate dimeglumine—Syncope—Epirubicin—pancreatic cancer	9.39e-05	0.000525	CcSEcCtD
Gadopentetate dimeglumine—Back pain—Doxorubicin—pancreatic cancer	9.37e-05	0.000524	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Docetaxel—pancreatic cancer	9.33e-05	0.000522	CcSEcCtD
Gadopentetate dimeglumine—Loss of consciousness—Epirubicin—pancreatic cancer	9.2e-05	0.000514	CcSEcCtD
Gadopentetate dimeglumine—Cough—Epirubicin—pancreatic cancer	9.13e-05	0.000511	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Docetaxel—pancreatic cancer	9.09e-05	0.000508	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Epirubicin—pancreatic cancer	9.07e-05	0.000507	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Epirubicin—pancreatic cancer	9.04e-05	0.000505	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Docetaxel—pancreatic cancer	8.96e-05	0.000501	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Epirubicin—pancreatic cancer	8.91e-05	0.000498	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Epirubicin—pancreatic cancer	8.91e-05	0.000498	CcSEcCtD
Gadopentetate dimeglumine—Agitation—Doxorubicin—pancreatic cancer	8.9e-05	0.000497	CcSEcCtD
Gadopentetate dimeglumine—Anxiety—Epirubicin—pancreatic cancer	8.88e-05	0.000496	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	8.85e-05	0.000495	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Doxorubicin—pancreatic cancer	8.73e-05	0.000488	CcSEcCtD
Gadopentetate dimeglumine—Dry mouth—Epirubicin—pancreatic cancer	8.71e-05	0.000487	CcSEcCtD
Gadopentetate dimeglumine—Syncope—Doxorubicin—pancreatic cancer	8.68e-05	0.000485	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Docetaxel—pancreatic cancer	8.67e-05	0.000484	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Epirubicin—pancreatic cancer	8.61e-05	0.000481	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Epirubicin—pancreatic cancer	8.54e-05	0.000477	CcSEcCtD
Gadopentetate dimeglumine—Loss of consciousness—Doxorubicin—pancreatic cancer	8.51e-05	0.000476	CcSEcCtD
Gadopentetate dimeglumine—Cough—Doxorubicin—pancreatic cancer	8.45e-05	0.000472	CcSEcCtD
Gadopentetate dimeglumine—Shock—Epirubicin—pancreatic cancer	8.4e-05	0.00047	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Doxorubicin—pancreatic cancer	8.39e-05	0.000469	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Epirubicin—pancreatic cancer	8.38e-05	0.000468	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Docetaxel—pancreatic cancer	8.37e-05	0.000468	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Doxorubicin—pancreatic cancer	8.36e-05	0.000467	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Epirubicin—pancreatic cancer	8.34e-05	0.000466	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Epirubicin—pancreatic cancer	8.3e-05	0.000464	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Epirubicin—pancreatic cancer	8.26e-05	0.000462	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Doxorubicin—pancreatic cancer	8.24e-05	0.000461	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Doxorubicin—pancreatic cancer	8.24e-05	0.000461	CcSEcCtD
Gadopentetate dimeglumine—Anxiety—Doxorubicin—pancreatic cancer	8.22e-05	0.000459	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	8.19e-05	0.000458	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Epirubicin—pancreatic cancer	8.14e-05	0.000455	CcSEcCtD
Gadopentetate dimeglumine—Dry mouth—Doxorubicin—pancreatic cancer	8.06e-05	0.000451	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Docetaxel—pancreatic cancer	8.05e-05	0.00045	CcSEcCtD
Gadopentetate dimeglumine—Rash—Docetaxel—pancreatic cancer	7.99e-05	0.000446	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Epirubicin—pancreatic cancer	7.98e-05	0.000446	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Docetaxel—pancreatic cancer	7.98e-05	0.000446	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Doxorubicin—pancreatic cancer	7.97e-05	0.000445	CcSEcCtD
Gadopentetate dimeglumine—Headache—Docetaxel—pancreatic cancer	7.93e-05	0.000443	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Doxorubicin—pancreatic cancer	7.9e-05	0.000442	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	7.78e-05	0.000435	CcSEcCtD
Gadopentetate dimeglumine—Shock—Doxorubicin—pancreatic cancer	7.78e-05	0.000435	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Doxorubicin—pancreatic cancer	7.75e-05	0.000433	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Doxorubicin—pancreatic cancer	7.71e-05	0.000431	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Doxorubicin—pancreatic cancer	7.68e-05	0.000429	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Epirubicin—pancreatic cancer	7.67e-05	0.000429	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Doxorubicin—pancreatic cancer	7.64e-05	0.000427	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Epirubicin—pancreatic cancer	7.62e-05	0.000426	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Epirubicin—pancreatic cancer	7.59e-05	0.000424	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Doxorubicin—pancreatic cancer	7.53e-05	0.000421	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Docetaxel—pancreatic cancer	7.52e-05	0.00042	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Epirubicin—pancreatic cancer	7.43e-05	0.000415	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Doxorubicin—pancreatic cancer	7.39e-05	0.000413	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	7.37e-05	0.000412	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Epirubicin—pancreatic cancer	7.36e-05	0.000412	CcSEcCtD
Gadopentetate dimeglumine—Pain—Epirubicin—pancreatic cancer	7.3e-05	0.000408	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Epirubicin—pancreatic cancer	7.3e-05	0.000408	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	7.2e-05	0.000403	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Doxorubicin—pancreatic cancer	7.1e-05	0.000397	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Doxorubicin—pancreatic cancer	7.05e-05	0.000394	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Epirubicin—pancreatic cancer	7.04e-05	0.000393	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Doxorubicin—pancreatic cancer	7.03e-05	0.000393	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Epirubicin—pancreatic cancer	6.98e-05	0.00039	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Doxorubicin—pancreatic cancer	6.87e-05	0.000384	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	6.82e-05	0.000381	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Doxorubicin—pancreatic cancer	6.81e-05	0.000381	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Epirubicin—pancreatic cancer	6.79e-05	0.000379	CcSEcCtD
Gadopentetate dimeglumine—Pain—Doxorubicin—pancreatic cancer	6.76e-05	0.000378	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Doxorubicin—pancreatic cancer	6.76e-05	0.000378	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Epirubicin—pancreatic cancer	6.75e-05	0.000377	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Epirubicin—pancreatic cancer	6.75e-05	0.000377	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Doxorubicin—pancreatic cancer	6.51e-05	0.000364	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	6.46e-05	0.000361	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Epirubicin—pancreatic cancer	6.29e-05	0.000352	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Doxorubicin—pancreatic cancer	6.28e-05	0.000351	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Doxorubicin—pancreatic cancer	6.25e-05	0.000349	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Doxorubicin—pancreatic cancer	6.25e-05	0.000349	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Epirubicin—pancreatic cancer	6.13e-05	0.000343	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Epirubicin—pancreatic cancer	6.04e-05	0.000338	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Epirubicin—pancreatic cancer	5.84e-05	0.000327	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Doxorubicin—pancreatic cancer	5.82e-05	0.000325	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Doxorubicin—pancreatic cancer	5.67e-05	0.000317	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Epirubicin—pancreatic cancer	5.65e-05	0.000316	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Doxorubicin—pancreatic cancer	5.59e-05	0.000313	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Epirubicin—pancreatic cancer	5.43e-05	0.000304	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Doxorubicin—pancreatic cancer	5.41e-05	0.000302	CcSEcCtD
Gadopentetate dimeglumine—Rash—Epirubicin—pancreatic cancer	5.39e-05	0.000301	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Epirubicin—pancreatic cancer	5.38e-05	0.000301	CcSEcCtD
Gadopentetate dimeglumine—Headache—Epirubicin—pancreatic cancer	5.35e-05	0.000299	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Doxorubicin—pancreatic cancer	5.23e-05	0.000292	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Epirubicin—pancreatic cancer	5.07e-05	0.000284	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Doxorubicin—pancreatic cancer	5.03e-05	0.000281	CcSEcCtD
Gadopentetate dimeglumine—Rash—Doxorubicin—pancreatic cancer	4.98e-05	0.000279	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Doxorubicin—pancreatic cancer	4.98e-05	0.000278	CcSEcCtD
Gadopentetate dimeglumine—Headache—Doxorubicin—pancreatic cancer	4.95e-05	0.000277	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Doxorubicin—pancreatic cancer	4.69e-05	0.000262	CcSEcCtD
